Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.
about
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaMasked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
P2860
Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@en
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@nl
type
label
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@en
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@nl
prefLabel
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@en
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@nl
P2093
P2860
P356
P1476
Masked polycythaemia vera: pre ...... eatment and clinical outcomes.
@en
P2093
Agueda Ancochea
Alberto Alvarez-Larrán
Anna Angona
Beatriz Bellosillo
Carlos Besses
Concepción Fernández
Francesc García-Pallarols
Raquel Longarón
P2860
P356
10.1111/EJH.12552
P577
2015-03-21T00:00:00Z